NewGenIvf (NIVF) Income from Non-Controlling Interests (2024 - 2025)
NewGenIvf (NIVF) posted quarterly Income from Non-Controlling Interests of $52969.0 for Q4 2025, up 8.0% YoY from $49044.0 in Q4 2024, and up 135.52% sequentially from -$149118.0 in Q3 2025.
NewGenIvf (NIVF) Income from Non-Controlling Interests (2024 - 2025) Analysis & Trends
NewGenIvf has disclosed Income from Non-Controlling Interests across 2 years of filings, most recently posting $52969.0 for Q4 2025.
- In Q4 2025, Income from Non-Controlling Interests rose 8.0% year-over-year to $52969.0; the TTM figure through Dec 2025 stood at -$124052.0 (changed N/A YoY), while the FY2025 annual figure was -$150685.0, down 398.14% from the prior year.
- Income from Non-Controlling Interests rose to $52969.0 in Q4 2025, from -$149118.0 in the prior quarter.
- Over the last five years, Income from Non-Controlling Interests for NIVF reached as high as $52969.0 in Q4 2025 and fell as low as -$149118.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 87.94 Bn | 90.32 Bn | 16.26 Bn | 237.00 Mn |
| 2 | Chemed | 18.08 Bn | 18.07 Bn | 215.76 Mn | - |
| 3 | Tenet Healthcare | 16.59 Bn | 15.76 Bn | 4.41 Bn | 204.00 Mn |
| 4 | Davita | 15.37 Bn | 16.23 Bn | 1.07 Bn | 77.51 Mn |
| 5 | Encompass Health | 10.07 Bn | 10.70 Bn | 1.34 Bn | 53.70 Mn |
| 6 | Ensign | 9.52 Bn | 8.93 Bn | 293.37 Mn | 88,000.00 |
| 7 | Universal Health Services | 9.19 Bn | 9.15 Bn | 3.21 Bn | 10.00 Mn |
| 8 | Pacs | 6.96 Bn | 6.72 Bn | 345.96 Mn | -27,000.00 |
| 9 | Ww International | 6.14 Bn | 5.98 Bn | -149.29 Mn | - |
| 10 | NewGenIvf | 25,304.95 | -1.41 Mn | 524,025.00 | 52,969.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 52,969.00 |
| Sep 30, 2025 | -149,118.00 |
| Dec 31, 2024 | 49,044.00 |
| Sep 30, 2024 | -76,947.00 |